BATS drops as sellers dominate short-term trend

BATS drops as sellers dominate short-term trend
British American Tobacco drops 2.42% today

British American Tobacco (BATS) stock is trading at GBX4,121, marking a daily decline of 2.42%. The price remains below its key moving averages, reflecting continued short-term and long-term pressure.

BATS price prediction
24H -0.08%
GBX 4,261.5
48H -0.2%
GBX 4,256.5
7D 0.18%
GBX 4,272.5
1M -1.2%
GBX 4,214
3M 11.46%
GBX 4,753.96
6M 16.77%
GBX 4,980.45
12M 5.42%
GBX 4,496.21
Current price: GBX 4,265 40.00 0.95%
Closed 10/14
Daily range 4215.00 Arrow from to Icon 4281.00
Weekly range 4075.00 Arrow from to Icon 4256.00
Loading...

Highlights

  • British American Tobacco repurchased 600,000 ordinary shares for cancellation between September 21 and September 25, 2026 as part of its ongoing buyback program.
  • The ongoing buyback directly reduces available float and may influence future liquidity, but prevailing selling pressure persists.
  • Shares of British American Tobacco trade below key moving averages and oscillators confirm strong intraday selling with a near-term price range forecast of GBX4,060 to GBX4,213.

Share buybacks raise per-share support amid continued selling pressure

British American Tobacco repurchased 600,000 ordinary shares for cancellation between September 21 and September 25, 2026, as part of its continuing share buyback programme, according to Tipranks. This direct reduction in available float provides mechanical support for per-share metrics, but does not appear to have offset prevailing selling pressures. The ongoing buyback may influence future liquidity conditions, though price action has remained under broader selling pressure.

British American Tobacco asset chart
British American Tobacco price dynamics. Source: TradingView.

Downside momentum builds as price breaches multi-period supports

The MA-20 and MA-50 are set at GBX4,210 and GBX4,211 respectively, with the price closing below both, and below the longer-term MA-200 at GBX4,386. The nearest resistance is represented by the Ichimoku Kijun at GBX4,234. Momentum indicators are mixed: MACD and ADX remain Neutral, while RSI at 43.25 and CCI signal Sell, and Stoch RSI indicates Oversold. Bull/Bear Power readings confirm sellers are dominant in intraday trading, and the Awesome Oscillator stands in Strong Sell, reinforcing the current downside momentum.

Weakness seen prevailing as rebound odds remain limited

In the short term, BATS is forecast to fluctuate within a volatility band of GBX4,060 to GBX4,213. There is a 24% probability of a rebound above resistance, while the downside scenario is favored at 76%, suggesting further weakness if support near the lower bound is breached. The base case sees price consolidating within this projected corridor; a bullish reversal would require a clear breakout above the Ichimoku Kijun.

Viktoras Karapetjanc, expert at Traders Union, sees British American Tobacco maintaining robust fundamentals despite continued share price pressure. He notes that the company’s ongoing buyback programme supports per-share metrics and demonstrates commitment to shareholder returns. Nonetheless, technical signals and prevailing sentiment still favor further downside in the near term. Karapetjanc believes that consolidation within the volatility band is likely unless a clear breakout above resistance occurs. "I view the persistent buybacks as a vote of confidence by management — and, with broader selling pressure in play, I will watch for signs of reversal above GBX4,234 before turning bullish."

Previously it was reported that British American Tobacco’s ongoing share buyback program had yet to overcome persistent technical selling pressure in the stock. The current setup strengthens that view, with prevailing downside risks and a volatility band between GBX4,060 and GBX4,213 warranting close attention to potential support breaks.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.